TECH
Bio-Techne Corporation$53.58-1.53 (-2.78%)Prev Close$55.11·MCap$9.17B·P/E108.26·Vol1.06M·Yield0.01%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
18
$16.59M
◆
Net Activity
Net Seller
$16.59M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Bio-Techne Corporation (TECH) has been exclusively selling, with 0 insider purchases totaling $0.00 and 18 insider sales totaling $16.59M. The most recent insider transaction was by Herr Amy E. (director), who sold $116.8K worth of shares on Feb 19, 2026. Bio-Techne Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $9.17B.
TECH Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Herr Amy E. | director | Sell | 1,976 | $59.10 | $116.8K | 200-91% |
| Feb 17, 2026 | Herr Amy E. | Director | Sell | 1,976 | $59.10 | $116.8K | 0 |
| Feb 3, 2026 | McManus Matthew | President - Diag & Spatial Bio | Sell | 1,665 | $64.09 | $106.7K | 0 |
| Nov 5, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 4,520 | $62.57 | $282.8K | 0 |
| Nov 5, 2025 | Hippel James | CFO | Sell | 11,865 | $62.57 | $742.4K | 0 |
| Nov 5, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 2,303 | $62.57 | $144.1K | 0 |
| Aug 27, 2025 | BAUMGARTNER ROBERT V | Director | Sell | 17,040 | $56.21 | $957.8K | 0 |
| Aug 27, 2025 | Nusse Roeland | Director | Sell | 17,040 | $56.36 | $960.4K | 0 |
| Aug 19, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 527 | $53.60 | $28.2K | 0 |
| Aug 19, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 803 | $53.60 | $43.0K | 0 |
| Aug 19, 2025 | Herr Amy E. | Director | Sell | 101 | $53.60 | $5.4K | 0 |
| Aug 19, 2025 | Hippel James | CFO | Sell | 1,926 | $53.60 | $103.2K | 0 |
| Aug 19, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 4,305 | $53.60 | $230.7K | 0 |
| Aug 19, 2025 | McManus Matthew | President - Diag & Spatial Bio | Sell | 880 | $53.60 | $47.2K | 0 |
| Jul 31, 2025 | Hippel James | CFO | Sell | 147,431 | $58.55 | $8.63M | 0 |
| Jul 24, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 43,649 | $53.12 | $2.32M | 0 |
| Jul 17, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 32,933 | $51.42 | $1.69M | 0 |
| Jun 11, 2025 | Herr Amy E. | Director | Sell | 1,280 | $49.77 | $63.7K | 0 |
| Apr 7, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 747 | $54.86 | $41.0K | 0 |
| Feb 18, 2025 | Herr Amy E. | Director | Sell | 1,860 | $65.96 | $122.7K | 0 |
| Feb 4, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 1,109 | $73.55 | $81.6K | 0 |
| Feb 4, 2025 | McManus Matthew | President - DGS | Sell | 1,642 | $73.55 | $120.8K | 0 |
| Jan 29, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 13,392 | $77.29 | $1.04M | 40,665 |
| Aug 12, 2024 | BAUMGARTNER ROBERT V | Director | Sell | 16,000 | $72.10 | $1.15M | 43,401-27% |
| May 16, 2024 | HIGGINS JOHN L | Director | Sell | 4,000 | $83.84 | $335.4K | 36,608 |
| Mar 11, 2024 | Nusse Roeland | Director | Sell | 10,400 | $76.98 | $800.6K | 43,097 |
| Sep 1, 2023 | Nusse Roeland | Director | Sell | 8,939 | $80.32 | $718.0K | 51,872 |
| Jul 25, 2023 | Kummeth Charles R. | Chief Executive Officer | Sell | 80,000 | $88.36 | $7.07M | 1,258,766 |
| Jun 9, 2023 | Kummeth Charles R. | Chief Executive Officer | Sell | 322 | $83.00 | $26.7K | 1,112,817 |
| Dec 9, 2022 | Furlow Brenda S. | SVP - GENERAL COUNSEL | Sell | 8,250 | $82.11 | $677.4K | 26,092 |
| Aug 12, 2022 | HIGGINS JOHN L | Director | Sell | 2,504 | $378.80 | $948.5K | 7,106-26% |
| Jun 9, 2022 | HIGGINS JOHN L | Sell | 1,600 | $364.98 | $584.0K | 4,606-26% | |
| Jun 9, 2022 | Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Sell | 5,104 | $365.00 | $1.86M | 198,338 |
| May 11, 2022 | BAUMGARTNER ROBERT V | Buy | 300 | $352.55 | $105.8K | 10,106 | |
| Nov 23, 2021 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 500 | $505.38 | $252.7K | 400-56% |
| Nov 16, 2021 | Eansor Norman David | President-Protein Sciences | Sell | 27,159 | $504.00 | $13.69M | 27,777-49% |
| Nov 3, 2021 | Hippel James | Chief Financial Officer | Sell | 9,022 | $526.49 | $4.75M | 16,011-36% |
| Nov 1, 2021 | Hippel James | Chief Financial Officer | Sell | 762 | $525.23 | $400.2K | 10,755 |
| Sep 24, 2021 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 822 | $529.04 | $434.9K | 0Exit |
| Sep 9, 2021 | STEER RANDOLPH C | Director | Sell | 8,000 | $509.98 | $4.08M | 10,212-44% |
| Sep 7, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 6,871 | $509.94 | $3.50M | 9,196-43% |
| Sep 7, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $507.22 | $5.07M | 10,862-48% |
| Sep 2, 2021 | Eansor Norman David | President-Protein Sciences | Sell | 1,538 | $503.07 | $773.7K | 1,318-54% |
| Sep 2, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 5,000 | $505.66 | $2.53M | 12,297-29% |
| Aug 25, 2021 | BAUMGARTNER ROBERT V | Director | Sell | 4,000 | $485.55 | $1.94M | 13,313 |
| Aug 25, 2021 | Nusse Roeland | Director | Sell | 4,000 | $481.52 | $1.93M | 6,765-37% |
| Aug 23, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 3,538 | $473.95 | $1.68M | 10,058-26% |
| Aug 10, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $478.90 | $4.79M | 15,655-39% |
| Jul 14, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $456.67 | $4.57M | 18,537-35% |
| Jun 21, 2021 | Kummeth Charles R. | Chief Executive Officer | Sell | 12,498 | $449.67 | $5.62M | 160,172 |
Showing 1–50 of 54
1 / 2
TECH Insider Buying Activity
The following table shows recent insider purchases of Bio-Techne Corporation (TECH) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 11, 2022 | BAUMGARTNER ROBERT V | Buy | 300 | $352.55 | $105.8K | 10,106 |
TECH Insider Selling Activity
The following table shows recent insider sales of Bio-Techne Corporation (TECH) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Herr Amy E. | director | Sell | 1,976 | $59.10 | $116.8K | 200-91% |
| Feb 17, 2026 | Herr Amy E. | Director | Sell | 1,976 | $59.10 | $116.8K | 0 |
| Feb 3, 2026 | McManus Matthew | President - Diag & Spatial Bio | Sell | 1,665 | $64.09 | $106.7K | 0 |
| Nov 5, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 4,520 | $62.57 | $282.8K | 0 |
| Nov 5, 2025 | Hippel James | CFO | Sell | 11,865 | $62.57 | $742.4K | 0 |
| Nov 5, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 2,303 | $62.57 | $144.1K | 0 |
| Aug 27, 2025 | BAUMGARTNER ROBERT V | Director | Sell | 17,040 | $56.21 | $957.8K | 0 |
| Aug 27, 2025 | Nusse Roeland | Director | Sell | 17,040 | $56.36 | $960.4K | 0 |
| Aug 19, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 527 | $53.60 | $28.2K | 0 |
| Aug 19, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 803 | $53.60 | $43.0K | 0 |
| Aug 19, 2025 | Herr Amy E. | Director | Sell | 101 | $53.60 | $5.4K | 0 |
| Aug 19, 2025 | Hippel James | CFO | Sell | 1,926 | $53.60 | $103.2K | 0 |
| Aug 19, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 4,305 | $53.60 | $230.7K | 0 |
| Aug 19, 2025 | McManus Matthew | President - Diag & Spatial Bio | Sell | 880 | $53.60 | $47.2K | 0 |
| Jul 31, 2025 | Hippel James | CFO | Sell | 147,431 | $58.55 | $8.63M | 0 |
| Jul 24, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 43,649 | $53.12 | $2.32M | 0 |
| Jul 17, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 32,933 | $51.42 | $1.69M | 0 |
| Jun 11, 2025 | Herr Amy E. | Director | Sell | 1,280 | $49.77 | $63.7K | 0 |
| Apr 7, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 747 | $54.86 | $41.0K | 0 |
| Feb 18, 2025 | Herr Amy E. | Director | Sell | 1,860 | $65.96 | $122.7K | 0 |
| Feb 4, 2025 | Geist William | PRESIDENT, PROTEIN SCIENCES | Sell | 1,109 | $73.55 | $81.6K | 0 |
| Feb 4, 2025 | McManus Matthew | President - DGS | Sell | 1,642 | $73.55 | $120.8K | 0 |
| Jan 29, 2025 | Kelderman Kim | Chief Executive Officer | Sell | 13,392 | $77.29 | $1.04M | 40,665 |
| Aug 12, 2024 | BAUMGARTNER ROBERT V | Director | Sell | 16,000 | $72.10 | $1.15M | 43,401-27% |
| May 16, 2024 | HIGGINS JOHN L | Director | Sell | 4,000 | $83.84 | $335.4K | 36,608 |
| Mar 11, 2024 | Nusse Roeland | Director | Sell | 10,400 | $76.98 | $800.6K | 43,097 |
| Sep 1, 2023 | Nusse Roeland | Director | Sell | 8,939 | $80.32 | $718.0K | 51,872 |
| Jul 25, 2023 | Kummeth Charles R. | Chief Executive Officer | Sell | 80,000 | $88.36 | $7.07M | 1,258,766 |
| Jun 9, 2023 | Kummeth Charles R. | Chief Executive Officer | Sell | 322 | $83.00 | $26.7K | 1,112,817 |
| Dec 9, 2022 | Furlow Brenda S. | SVP - GENERAL COUNSEL | Sell | 8,250 | $82.11 | $677.4K | 26,092 |
| Aug 12, 2022 | HIGGINS JOHN L | Director | Sell | 2,504 | $378.80 | $948.5K | 7,106-26% |
| Jun 9, 2022 | HIGGINS JOHN L | Sell | 1,600 | $364.98 | $584.0K | 4,606-26% | |
| Jun 9, 2022 | Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Sell | 5,104 | $365.00 | $1.86M | 198,338 |
| Nov 23, 2021 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 500 | $505.38 | $252.7K | 400-56% |
| Nov 16, 2021 | Eansor Norman David | President-Protein Sciences | Sell | 27,159 | $504.00 | $13.69M | 27,777-49% |
| Nov 3, 2021 | Hippel James | Chief Financial Officer | Sell | 9,022 | $526.49 | $4.75M | 16,011-36% |
| Nov 1, 2021 | Hippel James | Chief Financial Officer | Sell | 762 | $525.23 | $400.2K | 10,755 |
| Sep 24, 2021 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 822 | $529.04 | $434.9K | 0Exit |
| Sep 9, 2021 | STEER RANDOLPH C | Director | Sell | 8,000 | $509.98 | $4.08M | 10,212-44% |
| Sep 7, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 6,871 | $509.94 | $3.50M | 9,196-43% |
| Sep 7, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $507.22 | $5.07M | 10,862-48% |
| Sep 2, 2021 | Eansor Norman David | President-Protein Sciences | Sell | 1,538 | $503.07 | $773.7K | 1,318-54% |
| Sep 2, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 5,000 | $505.66 | $2.53M | 12,297-29% |
| Aug 25, 2021 | BAUMGARTNER ROBERT V | Director | Sell | 4,000 | $485.55 | $1.94M | 13,313 |
| Aug 25, 2021 | Nusse Roeland | Director | Sell | 4,000 | $481.52 | $1.93M | 6,765-37% |
| Aug 23, 2021 | Furlow Brenda S. | SVP - General Counsel | Sell | 3,538 | $473.95 | $1.68M | 10,058-26% |
| Aug 10, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $478.90 | $4.79M | 15,655-39% |
| Jul 14, 2021 | Hippel James | Chief Financial Officer | Sell | 10,000 | $456.67 | $4.57M | 18,537-35% |
| Jun 21, 2021 | Kummeth Charles R. | Chief Executive Officer | Sell | 12,498 | $449.67 | $5.62M | 160,172 |
TECH Insiders
Similar Stocks to TECH
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B